Replication_NN
of_IN
type_NN
1_CD
human_JJ
immunodeficiency_NN
viruses_NNS
containing_VBG
linker_NN
substitution_NN
mutations_NNS
in_IN
the_DT
-201_CD
to_TO
-130_CD
region_NN
of_IN
the_DT
long_JJ
terminal_JJ
repeat_NN
._.

In_IN
previous_JJ
transfection_NN
analyses_NNS
using_VBG
the_DT
chloramphenicol_NN
acetyltransferase_NN
reporter_NN
gene_NN
system_NN
,_,
we_PRP
determined_VBD
that_IN
linker_NN
substitution_NN
-LRB-_-LRB-
LS_NN
-RRB-_-RRB-
mutations_NNS
between_IN
-201_CD
and_CC
-130_CD
-LRB-_-LRB-
relative_JJ
to_TO
the_DT
transcription_NN
start_NN
site_NN
-RRB-_-RRB-
of_IN
the_DT
human_JJ
immunodeficiency_NN
virus_NN
type_NN
1_CD
long_JJ
terminal_JJ
repeat_NN
-LRB-_-LRB-
LTR_NN
-RRB-_-RRB-
caused_VBD
moderate_JJ
decreases_NNS
in_IN
LTR_NN
transcriptional_JJ
activity_NN
in_IN
a_DT
T-cell_NN
line_NN
-LRB-_-LRB-
S.L._NNP
Zeichner_NNP
,_,
J.Y.H._NNP
Kim_NNP
,_,
and_CC
J.C._NNP
Alwine_NNP
,_,
J._NNP
Virol_NNP
.65_CD
:_:
2436-2444_CD
,_,
1991_CD
-RRB-_-RRB-
._.

In_IN
order_NN
to_TO
confirm_VBP
the_DT
significance_NN
of_IN
this_DT
region_NN
in_IN
the_DT
context_NN
of_IN
viral_JJ
replication_NN
,_,
we_PRP
constructed_VBD
several_JJ
of_IN
these_DT
LS_NN
mutations_NNS
-LRB-_-LRB-
-201_CD
to_TO
-184_CD
,_,
-183_CD
to_TO
-166_CD
,_,
-165_CD
to_TO
-148_CD
,_,
and_CC
-148_CD
to_TO
-130_CD
-RRB-_-RRB-
in_IN
proviruses_NNS
and_CC
prepared_VBD
viral_JJ
stocks_NNS
by_IN
cocultivation_NN
of_IN
transfected_VBN
RD_NN
cells_NNS
with_IN
CEMx174_NN
cells_NNS
._.

In_IN
addition_NN
,_,
two_CD
mutations_NNS
between_IN
-93_CD
and_CC
-76_CD
and_CC
between_IN
-75_CD
and_CC
-58_CD
were_VBD
utilized_VBN
,_,
since_IN
they_PRP
affect_VBP
the_DT
nuclear_JJ
factor_NN
kappa_NN
B_NN
-LRB-_-LRB-
NF-kappa_NN
B_NN
-RRB-_-RRB-
-_:
and_CC
Sp1-binding_JJ
sites_NNS
and_CC
were_VBD
expected_VBN
to_TO
diminish_VB
viral_JJ
replication_NN
._.

Our_PRP$
results_NNS
suggest_VBP
that_IN
while_IN
transfection_NN
analyses_NNS
offer_VBP
an_DT
adequate_JJ
approximation_NN
of_IN
the_DT
effects_NNS
of_IN
the_DT
LS_NN
mutations_NNS
,_,
the_DT
analysis_NN
of_IN
viral_JJ
replication_NN
using_VBG
a_DT
mutant_JJ
viral_JJ
stock_NN
presents_VBZ
a_DT
more_RBR
accurate_JJ
picture_NN
,_,
which_WDT
is_VBZ
sometimes_RB
at_IN
variance_NN
with_IN
the_DT
transfection_NN
results_NNS
._.

Three_CD
mutants_NNS
-LRB-_-LRB-
-201_CD
\/_:
-184_CD
NXS_NN
,_,
-165_CD
\/_:
-148_CD
NXS_NN
,_,
and_CC
-147_CD
\/_:
-130_CD
NXS_NN
-RRB-_-RRB-
had_VBD
effects_NNS
on_IN
viral_JJ
replication_NN
that_WDT
were_VBD
much_RB
more_RBR
severe_JJ
than_IN
the_DT
effects_NNS
predicted_VBN
from_IN
their_PRP$
performance_NN
in_IN
transfection_NN
analyses_NNS
,_,
and_CC
the_DT
effects_NNS
of_IN
two_CD
LS_NN
mutations_NNS
-LRB-_-LRB-
-201_CD
\/_:
-184_CD
NXS_NN
and_CC
-183_CD
\/_:
-166_CD
NXS_NN
-RRB-_-RRB-
were_VBD
not_RB
predicted_VBN
by_IN
their_PRP$
effects_NNS
in_IN
transfection_NN
._.

In_IN
addition_NN
,_,
we_PRP
observed_VBD
cell_NN
type-specific_JJ
permissiveness_NN
to_TO
replication_NN
of_IN
some_DT
mutant_JJ
viruses_NNS
._.

In_IN
the_DT
cell_NN
types_NNS
tested_VBN
,_,
the_DT
LS_NN
mutations_NNS
indicated_VBD
an_DT
apparent_JJ
requirement_NN
not_RB
only_RB
for_IN
the_DT
intact_JJ
NF-kappa_NN
B_NN
and_CC
SP1-binding_JJ
sites_NNS
but_CC
also_RB
for_IN
several_JJ
regions_NNS
between_IN
-201_CD
and_CC
-130_CD
not_RB
previously_RB
associated_VBN
with_IN
viral_JJ
infectivity_NN
._.

